Lymphedema in tuberous sclerosis complex.
Identifieur interne : 006475 ( Ncbi/Merge ); précédent : 006474; suivant : 006476Lymphedema in tuberous sclerosis complex.
Auteurs : Alexandra L. Geffrey [États-Unis] ; Julianna E. Shinnick ; Brigid A. Staley ; Susana Boronat ; Elizabeth A. ThieleSource :
- American journal of medical genetics. Part A [ 1552-4833 ] ; 2014.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Lymphoedème (), Lymphoedème (génétique), Lymphoedème (épidémiologie), Mâle, Nourrisson, Nouveau-né, Protéines suppresseurs de tumeurs (génétique), Sclérose tubéreuse du cerveau (anatomopathologie), Sclérose tubéreuse du cerveau (génétique), Sclérose tubéreuse du cerveau (épidémiologie), Sérine-thréonine kinases TOR (génétique), Études rétrospectives.
- MESH :
- anatomopathologie : Sclérose tubéreuse du cerveau.
- génétique : Lymphoedème, Protéines suppresseurs de tumeurs, Sclérose tubéreuse du cerveau, Sérine-thréonine kinases TOR.
- épidémiologie : Lymphoedème, Sclérose tubéreuse du cerveau.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Lymphoedème, Mâle, Nourrisson, Nouveau-né, Études rétrospectives.
English descriptors
- KwdEn :
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Lymphedema (complications), Lymphedema (epidemiology), Lymphedema (genetics), Male, Middle Aged, Retrospective Studies, TOR Serine-Threonine Kinases (genetics), Tuberous Sclerosis (epidemiology), Tuberous Sclerosis (genetics), Tuberous Sclerosis (pathology), Tumor Suppressor Proteins (genetics).
- MESH :
- chemical , genetics : TOR Serine-Threonine Kinases, Tumor Suppressor Proteins.
- complications : Lymphedema.
- epidemiology : Lymphedema, Tuberous Sclerosis.
- genetics : Lymphedema, Tuberous Sclerosis.
- pathology : Tuberous Sclerosis.
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Retrospective Studies.
Abstract
Congenital lymphedema has been described as a possible rare association of tuberous sclerosis complex (TSC), with only six previous cases reported in the literature. TSC is an autosomal dominant, multisystem disorder connected to aberrant regulation of the mammalian target of rapamycin (mTOR) pathway. The aim of this study is to review cases of lymphedema in a large cohort of TSC patients. The medical records of 268 patients seen at The Herscot Center for Children and Adults with Tuberous Sclerosis Complex at the Massachusetts General Hospital from 2002 to 2012 were retrospectively reviewed for reports of lymphedema or edema of unknown etiology. Genotypic and phenotypic data were collected in accordance with institutional review board (IRB) approval. This cohort presents two new cases of congenital lymphedema in TSC patients and acquired lymphedema was found in eight additional cases. Thus, we report 10 new cases of lymphedema in TSC (4%). The two patients with congenital lymphedema were female, as were the previous six reported cases. The frequency of lymphedema reported here (4%) is higher than the estimated prevalence in the general population (0.133-0.144%), suggesting a higher frequency of lymphedema in TSC. This study shows that patients with TSC and lymphedema are more likely to be females with renal AMLs and suggests that congenital lymphedema is a gender-specific (female) manifestation of TSC. Exploration of the potential role of mTOR antagonists may be important in treatment of lymphedema in TSC patients.
DOI: 10.1002/ajmg.a.36469
PubMed: 24668795
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001599
- to stream PubMed, to step Curation: 001599
- to stream PubMed, to step Checkpoint: 001599
Links to Exploration step
pubmed:24668795Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema in tuberous sclerosis complex.</title>
<author><name sortKey="Geffrey, Alexandra L" sort="Geffrey, Alexandra L" uniqKey="Geffrey A" first="Alexandra L" last="Geffrey">Alexandra L. Geffrey</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Neurology, Massachusetts General Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Shinnick, Julianna E" sort="Shinnick, Julianna E" uniqKey="Shinnick J" first="Julianna E" last="Shinnick">Julianna E. Shinnick</name>
</author>
<author><name sortKey="Staley, Brigid A" sort="Staley, Brigid A" uniqKey="Staley B" first="Brigid A" last="Staley">Brigid A. Staley</name>
</author>
<author><name sortKey="Boronat, Susana" sort="Boronat, Susana" uniqKey="Boronat S" first="Susana" last="Boronat">Susana Boronat</name>
</author>
<author><name sortKey="Thiele, Elizabeth A" sort="Thiele, Elizabeth A" uniqKey="Thiele E" first="Elizabeth A" last="Thiele">Elizabeth A. Thiele</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24668795</idno>
<idno type="pmid">24668795</idno>
<idno type="doi">10.1002/ajmg.a.36469</idno>
<idno type="wicri:Area/PubMed/Corpus">001599</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001599</idno>
<idno type="wicri:Area/PubMed/Curation">001599</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001599</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001599</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001599</idno>
<idno type="wicri:Area/Ncbi/Merge">006475</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphedema in tuberous sclerosis complex.</title>
<author><name sortKey="Geffrey, Alexandra L" sort="Geffrey, Alexandra L" uniqKey="Geffrey A" first="Alexandra L" last="Geffrey">Alexandra L. Geffrey</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Neurology, Massachusetts General Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Shinnick, Julianna E" sort="Shinnick, Julianna E" uniqKey="Shinnick J" first="Julianna E" last="Shinnick">Julianna E. Shinnick</name>
</author>
<author><name sortKey="Staley, Brigid A" sort="Staley, Brigid A" uniqKey="Staley B" first="Brigid A" last="Staley">Brigid A. Staley</name>
</author>
<author><name sortKey="Boronat, Susana" sort="Boronat, Susana" uniqKey="Boronat S" first="Susana" last="Boronat">Susana Boronat</name>
</author>
<author><name sortKey="Thiele, Elizabeth A" sort="Thiele, Elizabeth A" uniqKey="Thiele E" first="Elizabeth A" last="Thiele">Elizabeth A. Thiele</name>
</author>
</analytic>
<series><title level="j">American journal of medical genetics. Part A</title>
<idno type="eISSN">1552-4833</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Lymphedema (complications)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (genetics)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>TOR Serine-Threonine Kinases (genetics)</term>
<term>Tuberous Sclerosis (epidemiology)</term>
<term>Tuberous Sclerosis (genetics)</term>
<term>Tuberous Sclerosis (pathology)</term>
<term>Tumor Suppressor Proteins (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (génétique)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Protéines suppresseurs de tumeurs (génétique)</term>
<term>Sclérose tubéreuse du cerveau (anatomopathologie)</term>
<term>Sclérose tubéreuse du cerveau (génétique)</term>
<term>Sclérose tubéreuse du cerveau (épidémiologie)</term>
<term>Sérine-thréonine kinases TOR (génétique)</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>TOR Serine-Threonine Kinases</term>
<term>Tumor Suppressor Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Sclérose tubéreuse du cerveau</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term>
<term>Tuberous Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Lymphedema</term>
<term>Tuberous Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Lymphoedème</term>
<term>Protéines suppresseurs de tumeurs</term>
<term>Sclérose tubéreuse du cerveau</term>
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Tuberous Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term>
<term>Sclérose tubéreuse du cerveau</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Congenital lymphedema has been described as a possible rare association of tuberous sclerosis complex (TSC), with only six previous cases reported in the literature. TSC is an autosomal dominant, multisystem disorder connected to aberrant regulation of the mammalian target of rapamycin (mTOR) pathway. The aim of this study is to review cases of lymphedema in a large cohort of TSC patients. The medical records of 268 patients seen at The Herscot Center for Children and Adults with Tuberous Sclerosis Complex at the Massachusetts General Hospital from 2002 to 2012 were retrospectively reviewed for reports of lymphedema or edema of unknown etiology. Genotypic and phenotypic data were collected in accordance with institutional review board (IRB) approval. This cohort presents two new cases of congenital lymphedema in TSC patients and acquired lymphedema was found in eight additional cases. Thus, we report 10 new cases of lymphedema in TSC (4%). The two patients with congenital lymphedema were female, as were the previous six reported cases. The frequency of lymphedema reported here (4%) is higher than the estimated prevalence in the general population (0.133-0.144%), suggesting a higher frequency of lymphedema in TSC. This study shows that patients with TSC and lymphedema are more likely to be females with renal AMLs and suggests that congenital lymphedema is a gender-specific (female) manifestation of TSC. Exploration of the potential role of mTOR antagonists may be important in treatment of lymphedema in TSC patients.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24668795</PMID>
<DateCreated><Year>2014</Year>
<Month>05</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>01</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>05</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-4833</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>164A</Volume>
<Issue>6</Issue>
<PubDate><Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>American journal of medical genetics. Part A</Title>
<ISOAbbreviation>Am. J. Med. Genet. A</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphedema in tuberous sclerosis complex.</ArticleTitle>
<Pagination><MedlinePgn>1438-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/ajmg.a.36469</ELocationID>
<Abstract><AbstractText>Congenital lymphedema has been described as a possible rare association of tuberous sclerosis complex (TSC), with only six previous cases reported in the literature. TSC is an autosomal dominant, multisystem disorder connected to aberrant regulation of the mammalian target of rapamycin (mTOR) pathway. The aim of this study is to review cases of lymphedema in a large cohort of TSC patients. The medical records of 268 patients seen at The Herscot Center for Children and Adults with Tuberous Sclerosis Complex at the Massachusetts General Hospital from 2002 to 2012 were retrospectively reviewed for reports of lymphedema or edema of unknown etiology. Genotypic and phenotypic data were collected in accordance with institutional review board (IRB) approval. This cohort presents two new cases of congenital lymphedema in TSC patients and acquired lymphedema was found in eight additional cases. Thus, we report 10 new cases of lymphedema in TSC (4%). The two patients with congenital lymphedema were female, as were the previous six reported cases. The frequency of lymphedema reported here (4%) is higher than the estimated prevalence in the general population (0.133-0.144%), suggesting a higher frequency of lymphedema in TSC. This study shows that patients with TSC and lymphedema are more likely to be females with renal AMLs and suggests that congenital lymphedema is a gender-specific (female) manifestation of TSC. Exploration of the potential role of mTOR antagonists may be important in treatment of lymphedema in TSC patients.</AbstractText>
<CopyrightInformation>© 2014 Wiley Periodicals, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Geffrey</LastName>
<ForeName>Alexandra L</ForeName>
<Initials>AL</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shinnick</LastName>
<ForeName>Julianna E</ForeName>
<Initials>JE</Initials>
</Author>
<Author ValidYN="Y"><LastName>Staley</LastName>
<ForeName>Brigid A</ForeName>
<Initials>BA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Boronat</LastName>
<ForeName>Susana</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Thiele</LastName>
<ForeName>Elizabeth A</ForeName>
<Initials>EA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>P01 NS024279</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>03</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Med Genet A</MedlineTA>
<NlmUniqueID>101235741</NlmUniqueID>
<ISSNLinking>1552-4825</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025521">Tumor Suppressor Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4JG2LF96VF</RegistryNumber>
<NameOfSubstance UI="C090570">tuberous sclerosis complex 2 protein</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014402" MajorTopicYN="N">Tuberous Sclerosis</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D025521" MajorTopicYN="N">Tumor Suppressor Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">edema</Keyword>
<Keyword MajorTopicYN="N">lymphatic abnormalities</Keyword>
<Keyword MajorTopicYN="N">lymphedema</Keyword>
<Keyword MajorTopicYN="N">tuberous sclerosis complex</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>05</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>01</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>3</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>3</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24668795</ArticleId>
<ArticleId IdType="doi">10.1002/ajmg.a.36469</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Massachusetts</li>
</region>
</list>
<tree><noCountry><name sortKey="Boronat, Susana" sort="Boronat, Susana" uniqKey="Boronat S" first="Susana" last="Boronat">Susana Boronat</name>
<name sortKey="Shinnick, Julianna E" sort="Shinnick, Julianna E" uniqKey="Shinnick J" first="Julianna E" last="Shinnick">Julianna E. Shinnick</name>
<name sortKey="Staley, Brigid A" sort="Staley, Brigid A" uniqKey="Staley B" first="Brigid A" last="Staley">Brigid A. Staley</name>
<name sortKey="Thiele, Elizabeth A" sort="Thiele, Elizabeth A" uniqKey="Thiele E" first="Elizabeth A" last="Thiele">Elizabeth A. Thiele</name>
</noCountry>
<country name="États-Unis"><region name="Massachusetts"><name sortKey="Geffrey, Alexandra L" sort="Geffrey, Alexandra L" uniqKey="Geffrey A" first="Alexandra L" last="Geffrey">Alexandra L. Geffrey</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006475 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 006475 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:24668795 |texte= Lymphedema in tuberous sclerosis complex. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:24668795" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |